Skip to main content
Biogen10-Q: Acquisition announced

Entered definitive agreement to acquire RayThera Inc. in June 2026

Source: Autobound Signal API · 74 signals tracked for Biogen · updated

Get Biogen's live signals in Claude or ChatGPT, or by API

AskWhat changed at Biogen this week? Use Autobound signals for biogen.com.

What happened

Biogen entered into a definitive agreement in June 2026 to acquire all issued and outstanding shares of RayThera Inc. This acquisition may require regulatory, IT, and clinical integration support upon deal closing.

Source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition announced

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
Quarter ended Jun 30, 2026
Fiscal year end
06/30
Filed
Jul 29, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Details

CIK
875045
Accession number
0000875045-26-000075
Timeframe
Current quarter
Quarter
Q2
Filing year
2026
Period end date
Jun 30, 2026
Why it matters
Integration needs coming
Signal category
Strategic

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
acquisitionAnnounced

Use this data

Get every 10-Q signal for Biogen and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Biogen this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/2b1ab40e-3354-469e-994b-f0fa3835a9ef returns this record as JSON. POST /v1/companies/enrich returns every signal for biogen.com.

{
  "signal_id": "2b1ab40e-3354-469e-994b-f0fa3835a9ef",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-11-09T06:30:46.378+00:00",
  "company": {
    "name": "Biogen",
    "domain": "biogen.com"
  },
  "data": {
    "detail": "Biogen entered into a definitive agreement in June 2026 to acquire all issued and outstanding shares of RayThera Inc. This acquisition may require regulatory, IT, and clinical integration support upon deal closing.",
    "metrics": {
      "timeframe": "current_quarter"
    },
    "quarter": "Q2",
    "summary": "Entered definitive agreement to acquire RayThera Inc. in June 2026",
    "excerpts": "In June 2026 we entered into a definitive agreement to acquire all of the issued and outstanding shares of RayThera Inc., a pri",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/875045/000087504526000075/biib-20260630.htm",
    "filing_date": "2026-07-29",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "06/30",
    "period_end_date": "2026-06-30",
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.